Exact Sciences Corp

EXAS

Company Profile

  • Business description

    Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

  • Contact

    5505 Endeavor Lane
    MadisonWI53719
    USA

    T: +1 608 284-5700

    E: [email protected]

    https://www.exactsciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    7,000

Stocks News & Analysis

etfs

ARK Innovation ETF has likely been a disappointment for most investors

Investors are fleeing for the exits amid the fund's underperformance this year.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,627.1053.700.63%
CAC 407,942.4258.790.75%
DAX 4024,036.11101.130.42%
Dow JONES (US)42,677.24114.83-0.27%
FTSE 1008,781.1281.810.94%
HKSE23,873.22191.740.81%
NASDAQ19,142.7172.75-0.38%
Nikkei 22537,491.8037.69-0.10%
NZX 50 Index12,698.4254.190.43%
S&P 5005,940.4623.14-0.39%
S&P/ASX 2008,402.2058.900.71%
SSE Composite Index3,391.5111.030.33%

Market Movers